Stites & Harbison, PLLC

In an effort to combat the ongoing opioid crisis, Congress passed in 2018 the Eliminating Kickbacks in Recovery Act (“EKRA”) imposing significant monetary penalties on anyone paying or receiving payment for referrals to a recovery home, clinical treatment facility, or laboratory. However, given its broad language, EKRA may reach organizations not involved with substance abuse treatment. Health care providers and laboratories, therefore, should be aware of EKRA and its implications on their practice. Health care attorney Shea Luna takes a look at EKRA in this Stites & Harbison Client Alert.

Privacy and Data Security attorney Sarah Cronan Spurlock will be a speaker at the 2024 Annual Meeting of the IADC July 6-11.

Chad McTighe and Sarah Spurlock will be the speakers for The Knowledge Group's Webinar on June 14, 2024 discussing the costs associated with unforeseen security risks.

On May 21, 2024, the Federal Circuit issued an en banc decision in LKQ Corp. v. GM Global Technology Operations LLC, No. 2021-2348, eliminating the long-established test for proving design patents invalid for being obvious as "improperly rigid" in favor of a more flexible approach. In doing so, it decided the same test for utility patent obviousness applies to design patents. IP attorney Trevor Graves takes a look at the case in this Stites & Harbison Client Alert.